Advances in Biodetection & Biosensors Keynote Speakers

Darryl Bornhop Professor, Vanderbilt University Dr. Darryl J. Bornhop received s B.S. in chemistry and his M.A. in environmental chemistry from the University of Missouri in Columbia and a Ph.D. in Analytical Chemistry under the direction of Dr. Norman J. Dovichi, at the University of Wyoming and the University of Alberta. After working in the private sector, he joined the faculty at Texas Tech University becoming Professor of Chemistry and Biochemistry in 2002. Dr. Bornhop is currently Professor of Chemistry at Vanderbilt University. His research interests are inter-disciplinary and include Chemical Biology, Chemical Analysis, Molecular Imaging, Nanoscale Sensing and the deployment of Personalized Medicine.
Christopher Lowe Professor, University of Cambridge, Director, Cambridge Academy of Therapeutic Sciences Professor Christopher R. Lowe was founder Director of the Institute of Biotechnology at the University of Cambridge and conducts research in both diagnostics and therapeutics in the healthcare biotechnology sector. He is a fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of Chemistry. He has 395 peer-reviewed publications, 8 books and monographs, >100 patents and has supervised >95 PhD students and has a number of national and international prizes: “Queen’s Award for Technological Achievement”; “Queen’s Anniversary Prize for Higher and Further Education”; “Most Entrepreneurial Scientist of the UK”; OBE in the Queen’s New Year Honours; BBSRC Commercial Innovator of the Year in 2011. He has been the driving force for the establishment of 11 spin-out companies including ProMetic Biosciences Inc (Market Cap $1.9-2.1B), Cambridge Sensors Ltd, Paramata Ltd, Psynova Neurotech Ltd and Royale Therapeutics Ltd., has a number of directorships and fosters entrepreneurship within the University via a Master’s in Bioscience Enterprise, the University’s Seed Fund Committee and other Business School and student-led activities. He is active in various government committees and in a number of legal and entrepreneurial roles. His group's primary research interest is in healthcare biotechnology, particularly where it is applied to the biopharmaceutical, sensors and diagnostics and enzyme and microbial technology sectors. The work is highly multidisciplinary and not only covers aspects of molecular biology, biochemistry, microbiology, chemistry, physics, electronics and engineering, but also the entire range from fundamental science to strategic and applied science. He is currently Director of the newly established Cambridge Academy of Therapeutic Sciences (CATS) within the University of Cambridge.
Koji Sode Chair, Tokyo University of Agriculture and Technology Dr. Koji SODE received B.S. in chemical engineering, M.S. in electrochemistry and PhD in engineering at Tokyo Institute of Technology. During his graduate student period, he engaged as a research fellow at Swiss Federal Institute of Technology, Zuerich (ETH-Z), Biotechnology Institute. He started his academic appointment as Research Associate at Tokyo Institute of Technology, following at the Research Center for Advanced Science and Technology, The University of Tokyo. In 1990, he was promoted as an Associated Professor, at the Department of Biotechnology, Tokyo University of Agriculture and Technology. In 2000, he was promoted as full Professor in the Department of Biotechnology. His current research interest is the biomolecular engineering for the development of novel biosensing system and for the synthetic biology based bioprocess design.